The new fund, 55North, will focus on investing in European startups.
Owen Lozman, a former investor at M Ventures, the corporate VC arm of German biotechnology company Merck, has launched a Copenhagen-based fund to invest in quantum technologies.
Lozman is managing partner of 55North, which will invest in quantum startups from lab to market in computing, sensing, communications and enabling tech.
Claiming to be the world’s largest pure-play quantum VC, it launched the €300m ($352m) fund with a first close of €134m.
The fund’s team includes general partners Helmut Katzberger, who was global practice lead at Amazon Web Services, and Kai Hudek, a former senior manager of product engineering at IonQ, a quantum computing company.
The fund has anchor investments from EIFO, Denmark’s state-owned export and investment fund, and Novo Holdings, the Danish biotech investment and holding company.
GCV data shows corporate-backed funding for quantum technologies has surged this year following recent technological breakthroughs that are bringing the technology closer to commercial viability. Global investment in quantum exceeded $1.25bn in the first quarter of 2025.
US chipmaker Nvidia has been a particularly prolific investor in the technology, backing three startups within the space of a week in September: the US’s Quantium and QuEra, and Australia’s PsiQuantum.
The new fund has invested in IQM Quantum Computers, a Finnish developer of full-stack superconducting quantum computers, and Kiutra, a German cryogenics cooling technology for quantum applications.
A GCV Powerlister in 2022, 2023, 2024 and 2025, Lozman spent more than seven years at Amsterdam-based M Ventures as a managing director and as a vice president of its performance materials fund. He also spent more than four years at parent Merck Group in research and development.
